# SAB Biotherapeutics, Inc. (SABS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SABS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -18.87M | $ -15.25M | $ 6.17M | $ 227.25M |
| 2025 | $ 0 | $ 13.59M | $ -46.80M | $ 5.95M | $ 151.49M |
| 2024 | $ 1.39M | $ -35.85M | $ -36.37M | $ 4.67M | $ 25.97M |
| 2023 | $ 2.42M | $ -45.62M | $ -27.37M | $ 5.91M | $ 57.30M |
| 2022 | $ 26.70M | $ -20.94M | $ -26.93M | $ 5.93M | $ 31.06M |
| 2021 | $ 72.36M | $ -20.38M | $ -10.65M | $ 8.52M | $ 38.55M |
| 2020 | $ 32.81M | $ 10.76M | N/A | $ 8.13M | $ 39.01M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 11.45 |

## Other views

- [Metrics](https://sponda.capital/en/SABS.md)
- [Charts](https://sponda.capital/en/SABS/charts.md)
- [Compare](https://sponda.capital/en/SABS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.